Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment 5. Debunking Myths in the US Healthcare System
Top Ten Searches
aldosteronism contrast dialysis vitamin d bicarbonate arf amyloidosis hypocalcemia renal artery husYour Article Summary
Antifibrotic Effects of Aldosterone Receptor Blocker (Spironolactone) in Patients with Chronic Kidney Disease
Renal Failure, 11/25/09
Guney I et al. – Spironolactone reduced both proteinuria and urinary TGF–beta1 excretion in CKD patients. It is considered that spironolactone would be beneficial to prevent progression of renal fibrosis in CKD.
Related Articles
Understanding Diabetes Mellitus And Kidney Disease
Nephrology Nursing Journal, 10/02/09
Relevance Score: 83%
Circulating soluble receptor of advanced glycation end product inversely correlates with atherosclerosis in patients with chronic kidney disease
Kidney International, 11/19/09
Relevance Score: 82%
Maintenance of elevated versus physiological iron indices in non-anaemic patients with chronic kidney disease: a randomized controlled trial
Nephrology Dialysis Transplantation, 11/17/09
Relevance Score: 82%
Diabetic kidney disease in the older adult: an update
Aging Health, 10/07/09
Relevance Score: 82%
So Just What Can I Eat? Nutritional Care in Patients with Diabetes Mellitus and Chronic Kidney Disease
Nephrology Nursing Journal, 10/06/09
Relevance Score: 82%
Today in Chronic Dz/Renal Failure...keeping you current
Receive free subspecialty "5-minute updates" via email
Potential New Therapeutic Agents for Diabetic Kidney Disease
American Journal of Kidney Diseases, 02/09/10
Raloxifene decreases serum malondialdehyde and nitric oxide levels in postmenopausal women with end-stage renal disease under chronic hemodialysis therapy
Journal of Obstetrics and Gynaecology Research, 02/09/10
Predicting the risk of hyperkalemia in patients with chronic kidney disease starting lisinopril
Pharmacoepidemiology and Drug Safety, 02/09/10
Article Search
Sponsor


See Latest Articles


